UCP 600 Article 12 — Nominated Bank Payment Obligations: When Authority Becomes Action

Introduction

The nominated bank's payment obligation is one of the most misunderstood concepts in documentary credit practice. The industry operates on a common assumption: if a credit names a nominated bank and the beneficiary presents complying documents, the nominated bank must pay. This assumption is incorrect. Article 12 grants the nominated bank authority to pay — not an obligation to pay. The distinction between authority and obligation is the structural foundation of the nominated bank's role, and the failure to maintain this distinction creates disputes that Article 12 resolves clearly but the market frequently ignores.

When a nominated bank exercises its authority and pays the beneficiary, it acts on its own behalf or on behalf of the issuing bank. The payment creates a reimbursement claim against the issuing bank under Article 13 (bank-to-bank reimbursement arrangements). But the nominated bank's decision to exercise its authority is discretionary — it may examine the documents, find them complying, and still decline to pay.

Failure Mode Analysis

Failure Mode 1: The Payment-Without-Reimbursement Gap

This failure occurs when a nominated bank exercises its authority and pays the beneficiary, but the issuing bank refuses to reimburse. The nominated bank has paid out funds but cannot recover them from the issuing bank. This creates a funding gap that the nominated bank must absorb. The cause may be a discrepancy in the documents that the nominated bank overlooked, or a dispute between the issuing bank and the beneficiary that the nominated bank did not anticipate. Article 13's reimbursement framework assumes the nominated bank will be reimbursed, but the nominated bank bears the risk if the issuing bank refuses.

Failure Mode 2: The Deferred Payment Undertaking Risk

When a nominated bank incurs a deferred payment undertaking under Article 12(b), it commits to paying at a future date. This undertaking is binding once made — the nominated bank cannot withdraw it even if the issuing bank subsequently refuses to reimburse. The nominated bank's deferred payment undertaking creates a credit exposure that extends beyond the presentation date. The risk is that the issuing bank's financial condition deteriorates between the date of the undertaking and the payment date, leaving the nominated bank exposed.

Failure Mode 3: The Negotiation Authority Mismatch

When a credit is available by negotiation at the nominated bank, the nominated bank has authority to negotiate — but negotiation is defined as the purchase of documents by advancing funds. The negotiation authority does not include authority to examine and then decline without consequence. If the nominated bank examines documents, finds them complying, and advances funds, it has negotiated. If it then discovers a discrepancy, it cannot reverse the negotiation. The mismatch between the examination process and the negotiation authority creates a situation where the nominated bank commits to funding before fully verifying compliance.

Deterministic Resolution Architecture

1. Classify the nominated bank's authority type. Determine whether the credit authorizes sight payment, acceptance, deferred payment, or negotiation. The authority type defines the nominated bank's payment obligation scope.

2. Verify the nominated bank's role overlap. Determine whether the nominated bank is also the confirming bank. If so, Article 8's obligation supersedes Article 12's discretion. If not, the nominated bank's authority is discretionary.

3. Assess the payment risk. Before the nominated bank exercises its authority, evaluate the risk of non-reimbursement by the issuing bank. Factor in the issuing bank's creditworthiness, the jurisdiction's legal framework, and the reimbursement arrangement specified in the credit.

4. Verify the reimbursement mechanism. If the credit specifies a reimbursing bank, confirm that the reimbursing bank is authorized and willing to honor the nominated bank's claim. If no reimbursing bank is named, Article 13's default rules apply.

5. Apply Article 14 examination before payment. The nominated bank must examine documents under Article 14 before exercising its authority. A payment made without examination creates a risk that the payment was not for complying documents.

6. Manage deferred payment exposure. If the nominated bank incurs a deferred payment undertaking, monitor the issuing bank's condition during the deferral period. Establish credit limits and risk controls for deferred payment exposures.

7. Resolve payment disputes using Article 16. If the nominated bank refuses to pay, it must comply with Article 16's notice requirements. If the beneficiary claims payment is owed, verify that the nominated bank exercised its authority and that the payment obligation exists.

8. Document the payment decision chain. Record the authority type, the examination result, the payment decision, and the reimbursement mechanism. This creates an audit trail for payment disputes.

Conclusion

The nominated bank's payment obligation is bounded by its authority. Article 12 grants the authority to act — payment, acceptance, deferred payment, or negotiation — but does not impose the obligation to act. When the nominated bank exercises its authority, it creates a payment that must be reimbursed by the issuing bank. When it declines, the beneficiary's recourse is to the issuing bank. The structural truth is that the nominated bank's role is a permission, not a mandate — and the difference between the two defines the payment risk architecture of every documentary credit with a nominated bank.

FAQ

Q: Can the nominated bank pay the beneficiary even if the documents are discrepant?
A: Yes, but this is not a complying payment. The nominated bank may choose to pay despite discrepancies — this is a voluntary decision, not an obligation. The payment creates a reimbursement claim against the issuing bank, which may reject the claim if the documents were discrepant.

Q: What happens if the nominated bank pays but the issuing bank refuses reimbursement?
A: The nominated bank's recourse depends on the reimbursement arrangement. If a reimbursing bank is named, the nominated bank may claim against the reimbursing bank. If no reimbursing bank is named, Article 13's default rules apply. The nominated bank may need to pursue the issuing bank directly.

Q: Is the nominated bank's payment final?
A: Payment by the nominated bank is final vis-à-vis the beneficiary. The beneficiary receives payment and is discharged from its obligations. The nominated bank's recourse for any reimbursement dispute is with the issuing bank, not the beneficiary.

Q: Can the nominated bank negotiate and then discover discrepancies?
A: Yes, but the negotiation is already complete. Once the nominated bank advances funds, it has negotiated. Any subsequent discovery of discrepancies is a reimbursement issue between the nominated bank and the issuing bank — the beneficiary has already received payment.

Q: Does the nominated bank earn interest on deferred payment undertakings?
A: Article 12 does not address interest. Interest arrangements are governed by the credit terms, interbank agreements, and applicable law. The nominated bank may charge interest on deferred payment undertakings as a commercial arrangement.

Source Notes

• Canonical authority: UCP 600 Articles 8, 12(b)–12(c), 13, 14, 16
• Context: Google News RSS scan (source titles indicate ICC Academy general content — context only, not legal authority)